The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Apr. 28, 2015

Filed:

Dec. 17, 2012
Applicant:

Olema Pharmaceuticals, Inc., San Francisco, CA (US);

Inventors:

Peter J. Kushner, San Francisco, CA (US);

David C. Myles, Berkeley, CA (US);

Cyrus L. Harmon, Bolinas, CA (US);

Leslie Carol Hodges Gallagher, Alameda, CA (US);

Assignee:

Olema Pharmaceuticals, Inc., San Francisco, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 405/12 (2006.01); A61K 31/4025 (2006.01); A61K 31/565 (2006.01); A61K 31/675 (2006.01); A61K 45/06 (2006.01); C07F 9/6558 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4025 (2013.01); A61K 31/565 (2013.01); A61K 31/675 (2013.01); A61K 45/06 (2013.01); C07D 405/12 (2013.01); C07F 9/65586 (2013.01);
Abstract

Benzopyran compounds with strong anti-estrogenic activity and essentially no estrogenic activity are provided, which are OP-1038, which is 3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol, and OP-1074, which is (2S)-3-(4-hydroxyphenyl)-4-methyl-2-(4-{2-[(3R)-3-methylpyrrolidin-1-yl]ethoxy}phenyl)-2H-chromen-7-ol. OP-1074 is a pure anti-estrogen when tested in the agonist mode and a complete anti-estrogen when tested in the antagonist mode. These compounds are useful for the treatment or prevention of a variety of conditions that are modulated through the estrogen receptor in mammals including humans.


Find Patent Forward Citations

Loading…